Women with an intact uterus treated for HRT must be prescribed both estrogen and progestin due to:

Reduced risk for colon cancer with combined therapy

Lower risk of developing venous thromboembolism with combined therapy

Increased risk for endometrial cancer if estrogen is used unopposed

Combination therapy providing the best relief of menopausal vasomotor symptoms